Protect (SDD)
Abstract
The Protect System Development & Demonstration (SDD) Project enhances mission performance and provides effective protection against current and emerging threats by rapidly developing and fielding modernized protection capabilities. Developmental efforts focus on advances in materials and systems engineering to enhance protective properties against a broader array of hazards, while reducing CWMD operational challenges and logistical burdens. Developmental efforts focus on advanced medical countermeasures that provide safe and effective medical defenses against biological agents (bacteria, toxins, and viruses), emerging infectious diseases, and chemical agents. Efforts included in this Project are: (1) Botulinum Monoclonal Antibodies (BOT MAB), (2) Uniform Integrated Protection Ensemble Family of Systems Air (UIPE FOS AIR), (3) UIPE FOS General Purpose (UIPE FOS GP), (4) UIPE FOS Gloves (UIPE FOS GLOVES), (5) Special Immunizations Program (VAC SIP) , (6) Advanced System for Protection and Integrated Reduction of Encumbrances-Enhanced Biodefense (ASPIRE-ENBD) , (7) Collective Protection Conex-Enhanced Biodefense (COL PRO CONEX-ENBD), and (8) Portable Biocontainment Patient Transport System-Enhanced Biodefense (PPTS-ENBD) The BOT MAB program was initiated by the Medical Countermeasure Platform Technologies (MCMPT). The goal of BOT MAB advanced development effort is to counter exposure to BOT A & B toxins. The program is leveraging the advanced platform technology developed within the DoD's Advanced Development Manufacturing (ADM) facility that was initiated by the MCMPT. The BOT MAB will be a monoclonal antibody cocktail that protects the warfighter against exposure to BOT A&B serotypes. FY23 funding is required to ensure large scale Good Manufacturing Practices (GMP) and execution product/process characterization /validation meets schedule. The UIPE FoS Air program will provide the Warfighter percutaneous protection from operationally relevant traditional and non-traditional Chemical, Biological, Radiological, Nuclear (CBRN) threats. UIPE FoS Air will improve aircrew performance and survivability under CBRN conditions by reducing thermal burden and bulk, while increasing mobility and resulting in an increase operational effectiveness. The UIPE FoS Air is composed of two variants. The UIPE FoS Air Chemical, Biological, Radiological Layer (CBRL) to address the specific requirements of the United States Air Force (USAF) tactical/ejection fixed wing platforms and the Two Piece Undergarment (2PUG) to address the remaining USAF and United States Navy / United States Marine Corps tactical/ejection seat (rotary wing) and non-ejection (fixed wing) platforms. In FY23, UIPE FoS Air will finalize EMD testing and conduct integration testing on 40+ USAF, USN, and USMC platforms for airworthiness, safe to fly and final flight clearance. UIPE FoS GP is part of a family of systems that will give the Warfighter percutaneous protection from operationally relevant traditional, non-traditional, and advanced CBRN/Toxic Industrial Material (TIM) threats likely to be encountered during joint force operations. The legacy chemical biological garment is nearing the end of its service life and does not meet updated requirements such as emerging threats, aerosol protection, and flame resistance. The UIPE FoS GP is a two-piece lightweight (compared to the legacy system) duty uniform replacement that has an aerosol liner, is flame resistant, and does not reduce Warfighter effectiveness in the areas of mobility and thermal burden. In FY23, UIPE FoS GP will conduct System Verification Review, complete MOT&E, award production contract, and conduct Production Verification Testing (PVT). In FY23, UIPE FoS GP program will obtain a MS C Low Rate Initial Production decision and conduct a Multi-Service Operational Test and Evaluation. UIPE FoS Gloves provides percutaneous protection to the hand and wrist interface of the warfighter against traditional and non-traditional CBRN threats. UIPE FoS Gloves will provide improved comfort, tactility and dexterity and for certain mission profiles enhanced touch screen and flame resistant capability. The UIPE FoS Gloves will be developed using a Middle Tier Acquisition (MTA) approach. In FY23 the UIPE FoS Gloves program will continue to conduct prototype development on multiple prototypes for multiple mission profiles (General Purpose, Aviation Heavy and Aviation Light). The SIP continually manages, updates, and executes the Investigational New Drugs (INDs) of selected prophylaxis, treatments and diagnostics development products which provide additional protection to individuals that are at high risk of exposure to CBRN agents. These vaccines will be used to provide additional levels of protection to laboratory workers conducting research. DoD has the mission to maintain IND vaccines in Good Manufacturing Practice (GMP) storage and to conduct the periodic potency and stability testing of these materials to support submissions to the FDA. In FY23 SIP continues storage, distribution, potency testing, and biosurety compliance activities. ASPIRE-ENBD, a new start program in FY23, supports unencumbering warfighters and revolutionizing respiratory and ocular protection against CBRN threats, including protection from biological, toxic industrial chemicals, and other emerging threats. ASPIRE provides a revolutionary new capability to address interface issues with new and emerging equipment. ASPIRE will unencumber the warfighter while still providing respiratory and ocular protection against CBRN agents, provide durable and extended wear capability, and incorporate anti-microbial materials to develop a reusable respirator. The solution will be optimized to minimize impact on the wearer's performance to continue lethality in CB environment by reducing burden, improving filtration capability, utilizing powered and supplied air systems as required, and integrate with existing and future equipment that cannot be integrated with current mask systems. ASPIRE will provide a revolutionized capability to the Services for the next generation of respiratory and ocular protection. The ASPIRE Enhanced Biodefense effort will develop half masks / bio-masks that are low-burden, provide protection against bio threats, and are designed as a reusable system with modularity and/or scalability for additional ocular protection. COL PRO CONEX-ENBD, a new start program in FY23, will provide rest and relief for aircrew in a Chemical, Biological, Radiological, and Nuclear (CBRN) environment. The CPC CBRN defense system provides an isolation area to treat infectious personnel and protecting embarked crew from infection. It is a modified container/Conex box that can be transported to host platform with minimal setup. The PPTS-ENBD, a new start program in FY23, is a patient transport system that enables safe transport of asymptomatic, symptomatic, or infected patients while ensuring that the medical attending personnel and platform crew members are protected from exposure.
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2023
- Source ID
- PT5_0604384BP_5_0400_PB_2023
Related Documents
- Root: CHEMICAL/BIOLOGICAL DEFENSE (EMD)
- Child Accomplishment: 1) ASPIRE - Enhanced Biodefense (ENBD)
- Child Accomplishment: 2) COL PRO CONEX - Enhanced Biodefense (ENBD)
- Child Accomplishment: 3) PPTS - Enhanced Biodefense (ENBD)
- Child Accomplishment: 4) Botulinum Monoclonal Antibodies (BOT MAB)
- Child Accomplishment: 5) Botulinum Monoclonal Antibodies (BOT MAB)
- Child Accomplishment: 6) UIPE FoS General Purpose (GP)
- Child Accomplishment: 7) UIPE FoS Air
- Child Accomplishment: 8) UIPE FoS Gloves
- Child Accomplishment: 9) VAC SIP
- Child Cost Item: 6c80cb3e8ee16a86ecad8da00258b5eb
- Child Cost Item: ff7e12b9a60d7eae1b273ec1d829e38f
- Child Cost Item: 6896eb3f227bd6e08ed481316b41062a
- Child Cost Item: cb419258fc6365b4f4c165dda2f1ebc4
- Child Cost Item: 73b59db01e24a7aca342d7d5dda2074d
- Child Cost Item: 72b060776e7e0f46fad2076f3f02d86d
- Child Cost Item: ec3da89690a5767f92da0823a8f7b263
- Child Cost Item: ce2492caab27f0b740291be11475b1df
- Child Cost Item: 011ad027d75434ba58d78c3a6af703c0
- Child Cost Item: 2bb640c67c8d34af1d37ea58239e553d
- Child Cost Item: 0f4417562191807a7881626ed7f30764
- Child Cost Item: 49187174531aa31a68a2ae40148379bf
- Child Cost Item: e1dbf8951548df5ac419465bfc3e8e1b
- Child Cost Item: 2c4ef4cd12d5387a6b77c3b74d0f5246
- Child Cost Item: e1c9b022eccd94a2ccf5ba6ca40f8405
- Child Cost Item: e811f99ba6fe49e8306ea2d883b42dff
- Child Cost Item: 8ac8586171e362528a6af03ace0ffb5c
- Child Cost Item: d6f4ba495cf5f0728b1410c58fc55f95
- Child Cost Item: 587a020886fcd28c27cac29c514800ec
- Child Cost Item: d4f21d2315b4b038367ee0d460c79648
- Child Cost Item: 38053d0f827a534469d0e19caf124a70
- Child Cost Item: d306e44d12167c98f5463937f82a6fb1
- Child Cost Item: b278d729bc4f74b88b87fa83e7072e1b
- Child Cost Item: dda71fb08d5e0aeaa785a68e68526e0b
- Child Cost Item: 99b50bab0e8ff6c24f5f720c6fbf9a0c
- Child Cost Item: 26a9a71248bb5f33df94f91a37e27864
- Child Cost Item: 096b3a3c5a2c2e8043cc7f8d6d7aaeb1
- Child Cost Item: 8e2f162bc9d625ba97db28071fcf0037
- Child Cost Item: 7b8addedb746868d3d187592ce5ed6c1
- Child Cost Item: 22faf62e8521905050a67c8bc10811a1
- Child Cost Item: cb8e2aace6e99b9950094bcc092c3d30
- Child Cost Item: 6d59d8bc9115a209211e95e1df12ce64